RNAi targeting EZH2 inhibits tumor growth and liver metastasis of pancreatic cancer in vivo

被引：51
|
作者：
Chen, Yangchao [1 ]
Xie, Dan [2 ]
Li, Wing Yin
Cheung, Chi Man
Yao, Hong [3 ,4 ]
Chan, Ching Yu
Chan, Chu-yan [3 ,4 ]
Xu, Fang-Ping [5 ]
Liu, Yan-Hui [5 ]
Sung, Joseph J. Y. [6 ]
Kung, Hsiang-fu [3 ,4 ]
机构：
[1] Chinese Univ Hong Kong, Sci Ctr N, Fac Med & Therapeut, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China
[2] Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China
[3] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, State Key Lab Oncol S China, Shatin, Hong Kong, Peoples R China
[5] Guangdong Prov Peoples Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China
[6] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China
来源：
CANCER LETTERS | 2010年 / 297卷 / 01期
关键词：
Enhancer of zeste homolog 2; Pancreatic cancer; Tumorigenecity; Liver metastasis; GROUP PROTEIN EZH2; POPULATION-BASED ANALYSIS; POLYCOMB-GROUP PROTEINS; OF-DEFENSE HOSPITALS; HEPATOCELLULAR-CARCINOMA; HEPATIC METASTASIS; DOWN-REGULATION; BREAST-CANCER; NUDE-MICE; EXPRESSION;
D O I：
10.1016/j.canlet.2010.05.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The function of EZH2 in tumorigenesis and liver metastasis of pancreatic cancer has never been elucidated in vivo. EZH2 was overexpressed in pancreatic carcinomas and its overexpression was associated with tumor differentiation and pT status. Suppression of EZH2 caused a significant growth inhibition of pancreatic cancer cells in vitro and markedly diminished their tumorigenicity in vivo. Knock-down of EZH2 inhibited liver metastasis of pancreatic cancer in vivo. EZH2 has a crucial role in tumor growth and liver metastasis of pancreatic cancer. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：109 / 116
页数：8
相关论文
共 50 条
  • [1] miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2
    Yu, Li
    Lu, Juan
    Zhang, Bao
    Liu, Xiong
    Wang, Lu
    Li, Si-Yang
    Peng, Xiao-Hong
    Xu, Xia
    Tian, Wen-Dong
    Li, Xiang-Ping
    ONCOLOGY LETTERS, 2013, 5 (04) : 1223 - 1228
  • [2] MicroRNA-144 Suppresses Prostate Cancer Growth and Metastasis by Targeting EZH2
    Sun, Xin-bo
    Chen, Yong-wei
    Yao, Qi-sheng
    Chen, Xu-hua
    He, Min
    Chen, Cong-bo
    Yang, Yong
    Gong, Xiao-xin
    Huang, Li
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [3] Targeting EZH2 in cancer
    Kimberly H Kim
    Charles W M Roberts
    Nature Medicine, 2016, 22 : 128 - 134
  • [4] Targeting EZH2 in cancer
    Kim, Kimberly H.
    Roberts, Charles W. M.
    NATURE MEDICINE, 2016, 22 (02) : 128 - 134
  • [5] MiR-32 Inhibits Proliferation and Metastasis by Targeting EZH2 in Glioma
    Zhang, Yuan
    Wang, Jiangang
    An, Wenzhi
    Chen, Chen
    Wang, Wencheng
    Zhu, Chao
    Chen, Fangzhou
    Chen, Huizhao
    Zheng, Wei
    Gong, Jie
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2019, 18
  • [6] Antihistamine Drug Ebastine Inhibits Cancer Growth by Targeting Polycomb Group Protein EZH2
    Li, Qiaqia
    Liu, Kilia Y.
    Liu, Qipeng
    Wang, Guangyu
    Jiang, Weihua
    Meng, Qingshu
    Yi, Yang
    Yang, Yongyong
    Wang, Rui
    Zhu, Sen
    Li, Chao
    Wu, Longxiang
    Zhao, Dongyu
    Yan, Lin
    Zhang, Lili
    Kim, Jung-Sun
    Zu, Xiongbing
    Kozielski, Anthony J.
    Qian, Wei
    Chang, Jenny C.
    Patnaik, Akash
    Chen, Kaifu
    Cao, Qi
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (10) : 2023 - 2033
  • [7] Inhibition of pancreatic cancer by targeting the epigenetic EZH2 complex.
    Lomberk, Gwen Alyce
    Mathison, Angela
    Missfeldt, Mckenna
    Salmonson, Ann
    Kossak, Sarah
    Buttar, Navtej
    Urrutia, Raul
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Targeting EZH2 in cancer therapy
    Yamagishi, Makoto
    Uchimaru, Kaoru
    CURRENT OPINION IN ONCOLOGY, 2017, 29 (05) : 375 - 381
  • [9] MiR-124-3p inhibits tumor progression in prostate cancer by targeting EZH2
    Bao-feng Song
    Li-zhe Xu
    Kun Jiang
    Fan Cheng
    Functional & Integrative Genomics, 2023, 23
  • [10] MiR-124-3p inhibits tumor progression in prostate cancer by targeting EZH2
    Song, Bao-feng
    Xu, Li-zhe
    Jiang, Kun
    Cheng, Fan
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2023, 23 (02)
12345